Here’s Why Venture Capitalists Like Juno

Aug. 7 (Bloomberg) -- Juno Therapeutics Scientific Co-Founder Michael Jensen and Second Avenue Partners Co-Founder Nick Hanauer discuss the Juno’s favor with venture capitalists. They speak on “Market Makers.” (Source: Bloomberg)
Greece Descended Into Circus With No Ringmaster: Alpert
06:48 - Westwood Capital Managing Partner Daniel Alpert weighs in on the Greek crisis in the wake of the referendum. He speaks on “Bloomberg Surveillance.” (Source: Bloomberg)
  • Greek, German Governments Need to Compromise: Orphanides
  • What Life Is Like in Greece After the Referendum
  • Pope Francis Begins South America Tour